MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Enhanced urinary excretion of albumin and beta 2 microglobulin in essential hypertension induced by atrial natriuretic peptide.
Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy.
Potassium accelerates urinary sodium excretion during salt loading without stimulating atrial natriuretic polypeptide secretion.
Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.
Atrial natriuretic peptide and cyclic guanosine monophosphate response to cardioversion of atrial flutter or fibrillation.
Urine calcium excretion, nephrogenous cyclic-adenosine monophosphate and serum parathyroid hormone levels in patients with essential hypertension.
Circadian rhythms in the urinary excretion of cyclic 3',5'-adenosine monophosphate (cyclic AMP) and cyclic 3',5'-guanosine monophosphate (cyclic GMP) in human subjects.
Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
Urinary cyclic adenosine 3',5'-monophosphate excretion in children in short stature: effect of somatotropin.
Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension.
Increased urinary excretion of cyclic guanosine monophosphate in rats bearing Morris hepatoma 3924A.
Atrial natriuretic peptide increases cyclic guanosine monophosphate immunoreactivity in the carotid body.
Atrial strain is the main determinant of release of atrial natriuretic peptide.
Differential effects of atrial natriuretic peptide and dopamine on urinary protein excretion in chronic glomerulonephritis.
Effects of atrial natriuretic peptide on glomerular filtration rate in essential hypertension: a radionuclide study.
The effect of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone?
Atrial natriuretic factor and renal sodium excretion during ventilation with PEEP in hypervolemic dogs.
Urinary prednisolone excretion is a determinant of serum hepcidin levels in renal transplant recipients.
Urinary sodium excretion is associated with short sleep duration.
Renal sites of action of physiological increases in plasma atrial natriuretic factor concentration in essential hypertension.
Effects of ketanserin on lipids, lipoproteins, and plasma atrial natriuretic factor in patients with essential hypertension.
Atrial natriuretic peptide lowering effect of antihypertensives in patients with essential hypertension.
Responses of atrial natriuretic factor to long-term sodium restriction in mild to moderate hypertension.
Effect of saline infusion on urinary calcium excretion in essential hypertension.
Is atrial natriuretic peptide-guanosine 3',5' cyclic monophosphate coupling a determinant of urinary sodium excretion in essential hypertension?
(1) To compare urinary guanosine 3',5' cyclic monophosphate (cyclic GMP) excretion between normotensive subjects and essential hypertensive patients; ...
630KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Enhanced urinary excretion of albumin and beta 2 microglobulin in essential hypertension induced by atrial natriuretic peptide.
Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy.
Potassium accelerates urinary sodium excretion during salt loading without stimulating atrial natriuretic polypeptide secretion.
Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.
Atrial natriuretic peptide and cyclic guanosine monophosphate response to cardioversion of atrial flutter or fibrillation.
Urine calcium excretion, nephrogenous cyclic-adenosine monophosphate and serum parathyroid hormone levels in patients with essential hypertension.
Circadian rhythms in the urinary excretion of cyclic 3',5'-adenosine monophosphate (cyclic AMP) and cyclic 3',5'-guanosine monophosphate (cyclic GMP) in human subjects.
Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
Urinary cyclic adenosine 3',5'-monophosphate excretion in children in short stature: effect of somatotropin.
Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms